| related words |
| biomedical |
| coating |
| diagnosis |
| zanaflex |
| intercept |
| viprinex |
| rilonacept |
| examined |
| prouroscan |
| snp |
| anodyne |
| eye |
| melanoma |
| tgs |
| clia |
| dispensing |
| oxygen |
| personalized |
| gambro |
| debarred |
|
| related documents |
| 2034--9/12/2006--ACETO_CORP |
| 820081--5/26/2006--CAMBREX_CORP |
| 1100412--8/15/2008--ARRAY_BIOPHARMA_INC |
| 1100412--9/13/2007--ARRAY_BIOPHARMA_INC |
| 1262175--2/29/2008--TERCICA_INC |
| 1262175--3/9/2007--TERCICA_INC |
| 906709--3/1/2007--NEKTAR_THERAPEUTICS |
| 1100412--8/12/2010--ARRAY_BIOPHARMA_INC |
| 844856--3/31/2010--VAPOR_CORP. |
| 1100412--8/18/2009--ARRAY_BIOPHARMA_INC |
| 887708--6/15/2009--CARACO_PHARMACEUTICAL_LABORATORIES_LTD |
| 877357--2/27/2009--SEPRACOR_INC_/DE/ |
| 2034--9/10/2007--ACETO_CORP |
| 1036968--8/30/2007--VAXGEN_INC |
| 1036968--5/31/2007--VAXGEN_INC |
| 749290--6/8/2007--SYNTHETECH_INC |
| 1100412--9/1/2006--ARRAY_BIOPHARMA_INC |
| 820081--3/15/2007--CAMBREX_CORP |
| 1036968--2/7/2007--VAXGEN_INC |
| 1262175--3/16/2006--TERCICA_INC |
|
| related topics |
| {regulation, government, change} |
| {product, candidate, development} |
| {cost, regulation, environmental} |
| {product, liability, claim} |
| {regulation, change, law} |
| {stock, price, operating} |
| {property, intellectual, protect} |
| {system, service, information} |
| {financial, litigation, operation} |
| {capital, credit, financial} |
| {condition, economic, financial} |
| {cost, contract, operation} |
| {personnel, key, retain} |
| {cost, operation, labor} |
| {interest, director, officer} |
| {loss, insurance, financial} |
| {provision, law, control} |
| {gas, price, oil} |
| {operation, international, foreign} |
| {loan, real, estate} |
|